menu
    • menu
    [{"orgOrder":0,"company":"Ousia Pharma","sponsor":"Omega Funds","pharmaFlowCategory":"D","therapeuticArea":"Nutrition and Weight Loss","country":"DENMARK","productType":"Peptide-drug Conjugate","year":"2025","type":"Financing","leadProduct":"OP-175","moa":"NMDA receptor","graph1":"Nutrition and Weight Loss","graph2":"Preclinical","graph3":"Ousia Pharma","amount2":0,"highestDevelopmentShortName":"Preclinical","therapeuticAreaShortName":"Nutrition & Weight Loss","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Ousia Pharma \/ Omega Funds","highestDevelopmentStatusID":"4","companyTruncated":"Ousia Pharma \/ Omega Funds"}]

    Find Clinical Drug Pipeline Developments & Deals by Ousia Pharma

    Menu

    Ousia Pharma

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Ousia Pharma

                            Denmark arrow
                            Bioequity Europe
                            Not Confirmed

                            Ousia Pharma

                            Denmark arrow
                            Bioequity Europe
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : OP-175

                            Therapeutic Area : Nutrition and Weight Loss

                            Study Phase : Preclinical

                            Sponsor : Omega Funds

                            Deal Size : Undisclosed

                            Deal Type : Financing

                            DEALS_DEV arrow-down

                            Ousia Pharma Secures Seed Funding Led by Omega Funds for Obesity Treatment

                            Details : The financing will support the development of a dual-incretin-NMDA receptor antagonist conjugate through preclinical and early clinical development for the treatment of obesity.

                            Product Name : OP-175

                            Product Type : Peptide-drug Conjugate

                            Upfront Cash : Undisclosed

                            May 06, 2025

                            Lead Product(s) : OP-175

                            Therapeutic Area : Nutrition and Weight Loss

                            Highest Development Status : Preclinical

                            Sponsor : Omega Funds

                            Deal Size : Undisclosed

                            Deal Type : Financing

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth